Related Experiment Video
Updated: May 19, 2026
06:39
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Historical perspectives on myelodysplastic syndromes
1Adult Leukemia Program, Department of Medical Oncology, Dana-Farber Cancer Institute Boston, MA, USA. david_steensma@dfci.harvard.edu
Leukemia Research
|August 28, 2012
Summary
Understanding the history of myelodysplastic syndromes (MDS) is crucial for advancing patient care. This review traces the evolution of MDS concepts from early observations to modern classifications and treatments.
Area of Science:
- Hematology
- Medical History
Background:
- Myelodysplastic syndromes (MDS) are complex bone marrow diseases with a long, evolving diagnostic history.
- Understanding the historical context is essential for interpreting current knowledge and future research directions in MDS.
Observation:
- Landmark observations predating the concept of MDS by centuries.
- Twentieth-century case studies and evolving terminology like 'refractory anemia' and 'preleukemia' paved the way for formal classification.
Findings:
- The French-American-British (FAB) Co-operative Group's classifications in 1976 and 1982 provided the first widely adopted framework for MDS.
- Recent advancements include mechanistic biological insights, new therapeutic approvals, and enhanced patient advocacy.
Implications:
- The historical trajectory of MDS offers valuable lessons for ongoing research and clinical practice.
- A comprehensive understanding of MDS history informs present strategies and future endeavors in managing these enigmatic blood disorders.
Related Concept Videos
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
01:24Cellular Adaptation IV: Dysplasia and Metaplasia
DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...
01:21Lineage Commitment
Commitment is the process whereby stem cells:
01:21Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...